WallStreetZenWallStreetZen

NASDAQ: CARA
CARA THERAPEUTICS INC Stock

$8.37-0.57 (-6.38%)
Updated May 18, 2022
CARA Price
$8.37
Fair Value Price
$8.77
Market Cap
$448.56M
52 Week Low
$7.40
52 Week High
$18.93
P/E
-4.68x
P/B
2.2x
P/S
25.12x
PEG
N/A
Dividend Yield
N/A
Revenue
$25.88M
Earnings
-$92.89M
Gross Margin
92%
Operating Margin
-358.88%
Profit Margin
-358.9%
Debt to Equity
0.1
Operating Cash Flow
-$62M
Beta
1.2
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

CARA Overview

Zen Score

Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how CARA scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

CARA ($8.37) is undervalued by 4.61% relative to our estimate of its Fair Value price of $8.77 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
CARA ($8.37) is not significantly undervalued (4.61%) relative to our estimate of its Fair Value price of $8.77 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
CARA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more CARA due diligence checks available for Premium users.

CARA News

Valuation

CARA fair value

Fair Value of CARA stock based on Discounted Cash Flow (DCF)
Price
$8.37
Fair Value
$8.77
Undervalued by
4.61%
CARA ($8.37) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
CARA ($8.37) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
CARA is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

CARA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-4.68x
Industry
-2.74x
Market
21.6x

CARA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.2x
Industry
4x
CARA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

CARA's financial health

Profit margin

Revenue
$4.8M
Net Income
-$27.7M
Profit Margin
-579.3%
CARA's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
CARA's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$223.9M
Liabilities
$19.8M
Debt to equity
0.1
CARA's short-term assets ($151.76M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CARA's short-term assets ($151.76M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CARA's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CARA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$25.5M
Investing
$33.4M
Financing
$3.0k
CARA's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

CARA vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
CARA$448.56M-6.38%-4.68x2.20x
NRIX$449.95M-4.21%-3.28x1.47x
VERA$444.36M-7.18%-6.92x3.31x
OCGN$444.26M-7.21%-6.06x3.39x
HUMA$453.22M-6.98%3.24x4.36x

CARA THERAPEUTICS Stock FAQ

What is CARA THERAPEUTICS's quote symbol?

(NASDAQ: CARA) CARA THERAPEUTICS trades on the NASDAQ under the ticker symbol CARA. CARA THERAPEUTICS stock quotes can also be displayed as NASDAQ: CARA.

What is the 52 week high and low for CARA THERAPEUTICS (NASDAQ: CARA)?

(NASDAQ: CARA) CARA THERAPEUTICS's 52-week high was $18.93, and its 52-week low was $7.40. It is currently -55.78% from its 52-week high and 13.11% from its 52-week low.

How much is CARA THERAPEUTICS stock worth today?

(NASDAQ: CARA) CARA THERAPEUTICS currently has 53,591,225 outstanding shares. With CARA THERAPEUTICS stock trading at $8.37 per share, the total value of CARA THERAPEUTICS stock (market capitalization) is $448.56M.

CARA THERAPEUTICS stock was originally listed at a price of $12.91 in Jan 31, 2014. If you had invested in CARA THERAPEUTICS stock at $12.91, your return over the last 8 years would have been -35.17%, for an annualized return of -5.27% (not including any dividends or dividend reinvestments).

How much is CARA THERAPEUTICS's stock price per share?

(NASDAQ: CARA) CARA THERAPEUTICS stock price per share is $8.37 today (as of May 18, 2022).

What is CARA THERAPEUTICS's Market Cap?

(NASDAQ: CARA) CARA THERAPEUTICS's market cap is $448.56M, as of May 19, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

CARA THERAPEUTICS's market cap is calculated by multiplying CARA's current stock price of $8.37 by CARA's total outstanding shares of 53,591,225.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.